yir-tufm-opa

(2:27:11)

yir-tufm-opa

(2:4:16)

yir-tufm-opa

(2:59:26)

yir-tufm-opa

(2:15:31)

yir-tufm-opa

(2:52:41)

yir-tufm-opa

(1:59:36)

yir-tufm-opa

(2:13:25)

yir-tufm-opa

(2:53:11)

yir-tufm-opa

(2:10:5)

yir-tufm-opa

(2:1:6)

yir-tufm-opa

(1:56:31)

yir-tufm-opa

(2:42:20)

R' Shmuel Lew Shares Tidbits from Yechidus | ר' שמואל לו: פנינים מיחידות

(20:24)

Rapamycin, mTOR, Autophagy and Treating mTOR Syndrome with Dr. Ross Pelton

(59:7)

yir-tufm-opa

(2:42:45)

An overview of mTOR and IGF-1 | Peter Attia

(3:9)

yir-tufm-opa

(2:2:5)

yir-tufm-opa

(1:58:20)

TNFR2 Taming Regulatory T Cells to Enhance Anti-Tumor Immunity

(11:39)

yir-tufm-opa

(2:40:1econd)

Translational microbiome research and FMT

(5:10)

TruSight™ Oncology 500 HRD at Oncopole Toulouse (France) ft. Dr. Guillaume Bataillon

(3:50)

yir-tufm-opa

(37:56)

yir-tufm-opa

(2:14:20)

yir-tufm-opa

(2:17:21)

yir-tufm-opa

(40:36)

yir-tufm-opa

(1:51:56)

yir-tufm-opa

(2:5:31)

yir-tufm-opa

(1:29:1econd)

yir-tufm-opa

(1:39:21)